Abstract
Background: We generally focused on an environmentally green synthesis and we used to
replace toxic methods, hazardous reaction conditions from the greener methods such as electro-organic
synthesis, use of visible light as an energy source, natural and biodegradable green catalysts etc.
Objective: Synthesis of biologically-active benzothiazole derivatives via eco-compatible method is
the objective of our research article.
Methods: Electrochemical method where electro-organic synthesis was carried out in an undivided
cell at room temperature in the presence of lithium perchlorate as a supporting electrolyte and electricity
was also utilized here instead of a chemical substance with a simple graphite-iron electrode
combination.
Results: The generation of 2-substituted benzothiazoles was achieved through the amalgamation of
bis(2- aminophenyl)disulfides with aromatic aldehydes under the influence of the electrodes. Products
were obtained here with the satisfactory to excellent yields with the range of 64% - 91%.
Conclusion: In conclusion, for the synthesis of benzothiazole derivatives, a different aqueous phase,
facile, simple and dexterous method that is free from any type of hazardous catalyst was reported.
This protocol represents a novel synthetic concept and an eco-compatible pathway along with green
chemistry expertise like usage of the nontoxic solvent with effortless work-up procedure.
Keywords:
Electro-catalysed, benzothiazoles, green synthesis, eco-compatible, sustainable chemistry, electro-organic synthesis.
Graphical Abstract
[5]
(a) Henriksen, G.; Hauser, A.I.; Westwell, A.D.; Yousefi, B.H.; Schwaiger, M.; Drzezga, A.; Wester, H.J. Metabolically stabilized benzothiazoles for imaging of amyloid plaques.
J. Med. Chem., 2007,
50(6), 1087-1089.
[
http://dx.doi.org/10.1021/jm061466g] [PMID:
17319654];
(b) Wang, M.; Gao, M.; Mock, B.H.; Miller, K.D.; Sledge, G.W.; Hutchins, G.D.; Zheng, Q.H. Synthesis of carbon-11 labeled fluorinated 2-arylbenzothiazoles as novel potential PET cancer imaging agents.
Bioorg. Med. Chem., 2006,
14(24), 8599-8607.
[
http://dx.doi.org/10.1016/j.bmc.2006.08.026] [PMID:
16962783];
(c) Mortimer, C.G.; Wells, G.; Crochard, J.P.; Stone, E.L.; Bradshaw, T.D.; Stevens, M.F.G.; Westwell, A.D. Antitumor benzothiazoles. 26. 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon, and breast cancer cell lines.
J. Med. Chem., 2006,
49(1), 179-185.
[
http://dx.doi.org/10.1021/jm050942k] [PMID:
16392802];
(d) Kamal, A.; Khan, M.N.A.; Reddy, K.S.; Srikanth, Y.V.V.; Sridhar, B.; Sridhar, B. Synthesis, structural characterization and biological evaluation of novel[1,2,4]triazolo[1,5-b][1,2,4]benzothiadiazine-benzothiazole conjugates as potential anticancer agents.
Chem. Biol. Drug Des., 2008,
71(1), 78-86.
[
http://dx.doi.org/10.1111/j.1747-0285.2007.00609.x] [PMID:
18086151];
(e) Liu, C.; Lin, J.; Pitt, S.; Zhang, R.F.; Sack, J.S.; Kiefer, S.E.; Kish, K.; Doweyko, A.M.; Zhang, H.; Marathe, P.H.; Trzaskos, J.; Mckinnon, M.; Dodd, J.H.; Barrish, J.C.; Schieven, G.L.; Leftheris, K. Benzothiazole based inhibitors of p38α MAP kinase.
Bioorg. Med. Chem. Lett., 2008,
18(6), 1874-1879.
[
http://dx.doi.org/10.1016/j.bmcl.2008.02.011] [PMID:
18296051]
[9]
Chen, Z.; Zeng, M.; Song, B.; Hou, C.; Hu, D.; Li, X.; Wang, Z.; Fan, H.; Bi, L.; Liu, J.; Yu, D. Dufulin activates HrBP1 to produce antiviral responses in tobacco. PLos One, 2012, 7(5), e37944.